|
Volumn 6, Issue 3, 2010, Pages 1-14
|
A multidisciplinary approach to the management of hepatocellular carcinoma
a b b c |
Author keywords
[No Author keywords available]
|
Indexed keywords
ALPHA FETOPROTEIN;
BEVACIZUMAB;
BRIVANIB;
CISPLATIN;
DOXORUBICIN;
GADOXETIC ACID;
GEMCITABINE;
MITOMYCIN C;
MITOXANTRONE;
NUCLEAR MAGNETIC RESONANCE IMAGING AGENT;
OXALIPLATIN;
SORAFENIB;
SUNITINIB;
ARTIFICIAL EMBOLISM;
CANCER CHEMOTHERAPY;
CANCER COMBINATION CHEMOTHERAPY;
CANCER DIAGNOSIS;
CANCER EPIDEMIOLOGY;
CANCER INCIDENCE;
CANCER MORTALITY;
CANCER SCREENING;
CANCER SURGERY;
CANCER SURVIVAL;
CARDIOTOXICITY;
CHEMOEMBOLIZATION;
CLINICAL FEATURE;
CLINICAL TRIAL;
COMPUTER ASSISTED TOMOGRAPHY;
CONFERENCE PAPER;
DIARRHEA;
DISEASE SURVEILLANCE;
DRUG DOSE REDUCTION;
EARLY DIAGNOSIS;
ETHNIC DIFFERENCE;
GEOGRAPHIC DISTRIBUTION;
HAND FOOT SYNDROME;
HUMAN;
LIVER BIOPSY;
LIVER CELL CARCINOMA;
LIVER DYSFUNCTION;
LIVER RESECTION;
MULTIMODALITY CANCER THERAPY;
NUCLEAR MAGNETIC RESONANCE IMAGING;
OVERALL SURVIVAL;
PROTEIN BLOOD LEVEL;
RACE DIFFERENCE;
RADIOEMBOLIZATION;
RADIOFREQUENCY ABLATION;
SIDE EFFECT;
SKIN MANIFESTATION;
SURGICAL TECHNIQUE;
SURVIVAL TIME;
TUMOR LOCALIZATION;
WEIGHT REDUCTION;
|
EID: 77951781372
PISSN: 15547914
EISSN: None
Source Type: Journal
DOI: None Document Type: Conference Paper |
Times cited : (29)
|
References (0)
|